FDA To Look At Study Linking Antibiotic To Cardiac Death

Law360, New York (May 17, 2012, 2:58 PM EDT) -- The U.S. Food and Drug Administration said it would review a medical study released Thursday that suggests that use of the popular antibiotic azithromycin may increase the risk of sudden cardiovascular death, especially in patients already at risk for cardiovascular disease.

The study, published in the New England Journal of Medicine, said that during five days of therapy, patients taking azithromycin, as opposed to patients who took no antibiotics, had an increased risk of cardiovascular death, as well as death from any cause.

Azithromycin also carried...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.